Earnings Date
Nov 2
EPS
$-1.080
Quarterly Revenue
$4.1M
Annual Revenue (as of Sep 30)
$9.4M
Earnings History
Analyze the earnings history of BridgeBio Pharma using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/22/2024 | AM | BBIO | Q4 | -$0.92 | — | — | — | $1.87M | — | — | — | Get Alert |
| 11/02/2023 | AM | BBIO | Q3 | -$0.93 | -$0.81 | -$1.08 | -33.33% | $338.00K | $4.26M | $4.09M | -3.97% | Get Alert |
| 08/03/2023 | AM | BBIO | Q2 | -$0.83 | -$0.83 | -$0.98 | -18.07% | $73.75M | $2.99M | $1.64M | -45.12% | Get Alert |
| 05/04/2023 | AM | BBIO | Q1 | -$1.35 | -$0.83 | -$0.92 | -10.84% | $1.69M | $3.37M | $1.83M | -45.82% | Get Alert |
| 02/23/2023 | AM | BBIO | Q4 | -$1.01 | -$0.85 | -$0.92 | -8.24% | $12.89M | $4.52M | $1.87M | -58.63% | Get Alert |
| 11/03/2022 | AM | BBIO | Q3 | -$1.06 | -$0.99 | -$0.93 | 6.06% | $2.34M | $7.90M | $338.00K | -95.72% | Get Alert |
| 08/04/2022 | AM | BBIO | Q2 | -$0.66 | -$0.63 | -$0.81 | -28.57% | $54.02M | $16.07M | $73.75M | 358.90% | Get Alert |
| 05/05/2022 | AM | BBIO | Q1 | -$1.18 | -$1.11 | -$1.19 | -7.21% | $462.00K | $4.69M | $1.69M | -63.88% | Get Alert |
| 02/24/2022 | AM | BBIO | Q4 | -$1.01 | -$0.87 | -$1.01 | -16.09% | $122.00K | $21.58M | $12.89M | -40.29% | Get Alert |
| 11/04/2021 | AM | BBIO | Q3 | -$0.98 | -$0.90 | -$1.06 | -17.78% | $8.13M | $17.36M | $2.34M | -86.50% | Get Alert |
| 08/05/2021 | AM | BBIO | Q2 | -$1.03 | -$0.96 | -$0.66 | 31.25% | $0.00 | $29.12M | $54.02M | 85.52% | Get Alert |
| 05/06/2021 | AM | BBIO | Q1 | -$0.78 | -$0.80 | -$1.18 | -47.50% | $0.00 | $32.10M | $462.00K | -98.56% | Get Alert |
| 02/25/2021 | AM | BBIO | Q4 | -$0.62 | — | -$1.01 | — | $13.82M | — | $122.00K | — | Get Alert |
| 11/05/2020 | AM | BBIO | Q3 | -$0.51 | — | -$0.98 | — | $26.74M | — | $8.13M | — | Get Alert |
| 08/11/2020 | AM | BBIO | Q2 | -$0.71 | — | -$1.03 | — | $0.00 | — | $0.00 | — | Get Alert |
| 05/13/2020 | PM | BBIO | Q1 | -$0.66 | — | -$0.78 | — | — | — | $0.00 | — | Get Alert |
| 03/02/2020 | AM | BBIO | Q4 | — | -$0.70 | -$0.62 | 11.43% | — | — | $13.82M | — | Get Alert |
| 11/07/2019 | AM | BBIO | Q3 | -$0.52 | — | -$0.51 | — | — | — | $26.74M | — | Get Alert |
| 08/14/2019 | AM | BBIO | Q2 | — | — | -$3.46 | — | — | — | $0.00 | — | Get Alert |
When is BridgeBio Pharma (NASDAQ:BBIO) reporting earnings?
BridgeBio Pharma (BBIO) is scheduled to report earnings on February 22, 2024. The last reported earnings were for reported on November 2, 2023 for Q3.
What were the latest earnings per share (EPS) for BridgeBio Pharma (NASDAQ:BBIO)?
The Actual EPS was $-1.08, which missed the estimate of $-0.81.
What were BridgeBio Pharma’s (NASDAQ:BBIO) revenues?
The Actual Revenue was $4.1M, which missed the estimate of $4.3M.
Browse earnings estimates, EPS, and revenue on all stocks.